Teva Pharmaceutical Industries (TEVA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Teva Pharmaceutical Industries Revenue Highlights

Latest Revenue (Y)

$15.85B

Latest Revenue (Q)

$4.33B

Main Segment (Y)

International Markets

Main Geography (Y)

North America

Teva Pharmaceutical Industries Revenue by Period

Teva Pharmaceutical Industries Revenue by Year

Date	Revenue	Change
2023-12-31	$15.85B	6.17%
2022-12-31	$14.93B	-6.00%
2021-12-31	$15.88B	-4.68%
2020-12-31	$16.66B	-1.36%
2019-12-31	$16.89B	-10.43%
2018-12-31	$18.85B	-15.77%
2017-12-31	$22.39B	2.20%
2016-12-31	$21.90B	11.45%
2015-12-31	$19.65B	-3.06%
2014-12-31	$20.27B	-0.21%
2013-12-31	$20.31B	-0.01%
2012-12-31	$20.32B	10.95%
2011-12-31	$18.31B	13.59%
2010-12-31	$16.12B	15.99%
2009-12-31	$13.90B	25.39%
2008-12-31	$11.09B	17.83%
2007-12-31	$9.41B	11.89%
2006-12-31	$8.41B	60.14%
2005-12-31	$5.25B	9.41%
2004-12-31	$4.80B	46.47%
2003-12-31	$3.28B	30.09%
2002-12-31	$2.52B	21.24%
2001-12-31	$2.08B	18.72%
2000-12-31	$1.75B	36.45%
1999-12-31	$1.28B	14.92%
1998-12-31	$1.12B	-0.09%
1997-12-31	$1.12B	17.10%
1996-12-31	$953.80M	42.85%
1995-12-31	$667.70M	13.61%
1994-12-31	$587.70M	17.07%
1993-12-31	$502.00M	-

Teva Pharmaceutical Industries generated $15.85B in revenue during NA 2023, up 6.17% compared to the previous quarter, and up 84.05% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue by Quarter

Date	Revenue	Change
2024-09-30	$4.33B	4.08%
2024-06-30	$4.16B	8.61%
2024-03-31	$3.83B	-14.02%
2023-12-31	$4.46B	15.77%
2023-09-30	$3.85B	-0.72%
2023-06-30	$3.88B	5.93%
2023-03-31	$3.66B	-5.74%
2022-12-31	$3.88B	8.04%
2022-09-30	$3.60B	-5.02%
2022-06-30	$3.79B	3.39%
2022-03-31	$3.66B	-10.71%
2021-12-31	$4.10B	5.51%
2021-09-30	$3.89B	-0.61%
2021-06-30	$3.91B	-1.81%
2021-03-31	$3.98B	-10.56%
2020-12-31	$4.45B	11.92%
2020-09-30	$3.98B	2.79%
2020-06-30	$3.87B	-11.18%
2020-03-31	$4.36B	-2.48%
2019-12-31	$4.47B	4.78%
2019-09-30	$4.26B	-1.68%
2019-06-30	$4.34B	0.98%
2019-03-31	$4.29B	-5.79%
2018-12-31	$4.56B	0.66%
2018-09-30	$4.53B	-3.66%
2018-06-30	$4.70B	-7.19%
2018-03-31	$5.07B	-7.22%
2017-12-31	$5.46B	-2.69%
2017-09-30	$5.61B	-1.34%
2017-06-30	$5.69B	0.99%
2017-03-31	$5.63B	-13.28%
2016-12-31	$6.49B	16.70%
2016-09-30	$5.56B	10.42%
2016-06-30	$5.04B	4.74%
2016-03-31	$4.81B	-1.45%
2015-12-31	$4.88B	1.20%
2015-09-30	$4.82B	-2.88%
2015-06-30	$4.97B	-0.32%
2015-03-31	$4.98B	-3.60%
2014-12-31	$5.17B	2.17%
2014-09-30	$5.06B	0.26%
2014-06-30	$5.04B	0.88%
2014-03-31	$5.00B	-7.90%
2013-12-31	$5.43B	7.33%
2013-09-30	$5.06B	2.74%
2013-06-30	$4.92B	0.47%
2013-03-31	$4.90B	-6.63%
2012-12-31	$5.25B	5.57%
2012-09-30	$4.97B	-0.44%
2012-06-30	$4.99B	-2.12%
2012-03-31	$5.10B	-10.11%
2011-12-31	$5.68B	30.66%
2011-09-30	$4.34B	3.13%
2011-06-30	$4.21B	3.24%
2011-03-31	$4.08B	-7.65%
2010-12-31	$4.42B	3.95%
2010-09-30	$4.25B	11.84%
2010-06-30	$3.80B	4.02%
2010-03-31	$3.65B	-3.92%
2009-12-31	$3.80B	7.10%
2009-09-30	$3.55B	4.41%
2009-06-30	$3.40B	8.04%
2009-03-31	$3.15B	10.50%
2008-12-31	$2.85B	0.21%
2008-09-30	$2.84B	0.67%
2008-06-30	$2.82B	9.76%
2008-03-31	$2.57B	-

Teva Pharmaceutical Industries generated $4.33B in revenue during Q3 2024, up 4.08% compared to the previous quarter, and up 111.71% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue Breakdown

Teva Pharmaceutical Industries Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Other Activities	$926.00M	$1.04B	$1.15B	$1.30B	$1.30B
International Markets	$1.96B	$1.90B	$2.03B	$2.15B	$2.25B

Teva Pharmaceutical Industries's latest annual revenue breakdown by segment (product or service), as of Dec 23: International Markets (67.89%), and Other Activities (32.11%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Product	$3.79B	$3.64B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product and Service, Other	$102.00M	$106.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License	$45.00M	$36.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distribution Service	$390.00M	$382.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Activities	-	-	$462.00M	$245.00M	$219.00M	$272.00M	$241.00M	$257.00M	$275.00M	$302.00M	$262.00M	$298.00M	$289.00M	$345.00M	$316.00M	$335.00M	$307.00M	$332.00M	$314.00M	-
International Markets	-	-	$987.00M	$479.00M	$492.00M	$481.00M	$475.00M	$454.00M	$492.00M	$527.00M	$530.00M	$485.00M	$490.00M	$572.00M	$529.00M	$488.00M	$565.00M	$101.00M	$736.00M	-
TREANDA and BENDEKA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$115.00M
Pro Air	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$65.00M
Austedo	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$96.00M
Anda	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$351.00M
AJOVY	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$23.00M
QVAR	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$60.00M

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (87.60%), Distribution Service (9.00%), Product and Service, Other (2.36%), and License (1.04%).

Teva Pharmaceutical Industries Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
North America	$8.12B	$5.83B	$6.39B	$6.90B	$6.94B
Europe	$4.84B	$4.46B	$4.81B	$4.74B	$4.77B

Teva Pharmaceutical Industries's latest annual revenue breakdown by geography, as of Dec 23: North America (62.68%), and Europe (37.32%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
UNITED STATES	$2.23B	$2.11B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Europe	$1.26B	$1.21B	$2.51B	$1.15B	$1.18B	$1.16B	$1.03B	$1.13B	$1.13B	$1.25B	$1.20B	$1.19B	$1.18B	$1.25B	$7.00M	$1.00B	$1.37B	$7.00M	$1.15B	$1.17B
North America	-	-	$5.23B	$1.58B	$1.32B	$1.53B	$1.39B	$1.54B	$1.38B	$1.62B	$1.49B	$1.62B	$1.67B	$1.96B	$1.66B	$1.66B	$1.63B	$1.94B	$1.67B	$1.69B

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (63.75%), and Europe (36.25%).

Teva Pharmaceutical Industries Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TAK	Takeda Pharmaceutical	$4.26T	$1.05T
TEVA	Teva Pharmaceutical Industries	$15.85B	$4.33B
VTRS	Viatris	$15.43B	$3.74B
HLN	Haleon	$11.30B	$2.92B
BHC	Bausch Health Companies	$8.76B	$2.51B
ZTS	Zoetis	$8.54B	$2.39B
ELAN	Elanco Animal Health	$4.42B	$1.18B
SNDL	SNDL	$909.01M	$197.75M
TLRY	Tilray Brands	$788.94M	$200.04M
CGC	Canopy Growth	$297.15M	$73.96M
ACB	Aurora Cannabis	$233.29M	$64.42M
LFCR	Lifecore Biomedical	$128.26M	$24.70M
CRON	Cronos Group	$120.27M	$38.68M
SHPH	Shuttle Pharmaceuticals	-	-

TEVA Revenue FAQ

What is Teva Pharmaceutical Industries’s yearly revenue?

Teva Pharmaceutical Industries's yearly revenue for 2023 was $15.85B, representing an increase of 6.17% compared to 2022. The company's yearly revenue for 2022 was $14.92B, representing a decrease of -6.00% compared to 2021. TEVA's yearly revenue for 2021 was $15.88B, representing a decrease of -4.68% compared to 2020.

What is Teva Pharmaceutical Industries’s quarterly revenue?

Teva Pharmaceutical Industries's quarterly revenue for Q3 2024 was $4.33B, a 4.08% increase from the previous quarter (Q2 2024), and a 12.52% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $4.16B, a 8.61% increase from the previous quarter (Q1 2024), and a 7.32% increase year-over-year (Q2 2023). TEVA's quarterly revenue for Q1 2024 was $3.83B, a -14.02% decrease from the previous quarter (Q4 2023), and a 4.67% increase year-over-year (Q1 2023).

What is Teva Pharmaceutical Industries’s revenue growth rate?

Teva Pharmaceutical Industries's revenue growth rate for the last 3 years (2021-2023) was -0.20%, and for the last 5 years (2019-2023) was -6.16%.

What are Teva Pharmaceutical Industries’s revenue streams?

Teva Pharmaceutical Industries's revenue streams in c 23 are Other Activities, and International Markets. Other Activities generated $926M in revenue, accounting 32.11% of the company's total revenue, down -11.39% year-over-year. International Markets generated $1.96B in revenue, accounting 67.89% of the company's total revenue, up 2.89% year-over-year.

What is Teva Pharmaceutical Industries’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Teva Pharmaceutical Industries was International Markets. This segment made a revenue of $1.96B, representing 67.89% of the company's total revenue.